Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Flamel Technologies SA (NASDAQ:FLML)

12.49
Delayed Data
As of Jul 22
 -0.07 / -0.56%
Today’s Change
7.56
Today|||52-Week Range
26.09
+2.29%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$515.1M

Company Description

Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France.

Contact Information

Flamel Technologies SA
33, avenue du Dr. Georges Lévy
Vénissieux Rhone-alpes 69200
P:(347) 278-3434
Investor Relations:

Employees

Shareholders

Other institutional51.35%
Mutual fund holders22.24%
Individual stakeholders--

Top Executives

Michael Shannon AndersonChief Executive Officer & Director
Scott A. MackeVice President-Supply Chain & Operations
Michael F. KananChief Financial Officer & Senior Vice President
David MonteithVice President-Research & Development
Phillandas T. ThompsonSecretary, Senior Vice President & General Counsel